about
MicroRNA dysregulation in diabetic ischemic heart failure patientsGenetics of cardiovascular and renal complications in diabetesβ-Cell MicroRNAs: Small but PowerfulThe Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingTGF-β/Smad signaling in renal fibrosisSmads as therapeutic targets for chronic kidney diseaseMicroRNAs in Diabetic Kidney DiseaseCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesEpigenetics of progression of chronic kidney disease: fact or fantasy?miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsMicroRNAs: a new ray of hope for diabetes mellitusRole of the TGF-β/BMP-7/Smad pathways in renal diseasesDifferential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita heartsTGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansionmicroRNA in the development of diabetic complications.MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathyInsulin regulates glucose consumption and lactate production through reactive oxygen species and pyruvate kinase M2.MicroRNAs and metabolic disorders - where are we heading?Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cellsIntegrated miRNA, mRNA and protein expression analysis reveals the role of post-transcriptional regulation in controlling CHO cell growth rate.Gadd45α: a novel diabetes-associated gene potentially linking diabetic cardiomyopathy and baroreflex dysfunction.Urinary microRNA profiling in the nephropathy of type 1 diabetes.Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1.Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.Urinary exosomal microRNAs in incipient diabetic nephropathy.Epigenetic mechanisms in diabetic complications and metabolic memory.MicroRNAs in renal fibrosis.Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.The miR-322-TRAF3 circuit mediates the pro-apoptotic effect of high glucose on neural stem cells.The Generation of Insulin Producing Cells from Human Mesenchymal Stem Cells by MiR-375 and Anti-MiR-9.Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy miceQualitative and Quantitative Analysis of Histone Deacetylases in Kidney Tissue Sections.Recent developments in epigenetics of acute and chronic kidney diseases.A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats.PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Association study of polymorphisms in miRNAs with T2DM in Chinese population.Comprehensive approach to diabetic nephropathy.Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus.The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.
P2860
Q24618462-F641B03B-19FF-4662-B11F-7598B74CBC1FQ26752749-40804943-2CF8-4590-BC70-629552677813Q26780370-3F256058-4758-4230-B12F-992FAEDC57DDQ26827627-49CC22E2-DF2D-44A1-B4C5-A4DB6CB50535Q26851198-41454578-32F7-4535-ADD6-CB9AF1D5FEE2Q26865998-72385FF6-1031-4620-8C30-5D9544FB4A73Q27002171-E12FD244-EC43-4225-BF4F-77A0DBC87F73Q27002459-0177F7C7-9EAE-43B3-8C6A-92873E0ADD67Q27005788-076ABB0E-1289-4ADC-A0AB-B226C80AAB5EQ27023295-95854187-86CC-462E-88E1-FCC76DB48590Q27028201-5199ED42-CF75-4C50-AF50-1BCA6BF48A02Q28278757-3D119129-AB0B-47E4-90B8-6B4E7A700A34Q28293366-E2F4BFEA-C731-4E15-AAA4-BE3D3D9CEA0EQ28975741-A4D68E24-038A-48C3-A6C4-2C3148416708Q30353835-DA30213E-1741-4564-A716-C83F55FBCE07Q33653982-3337D006-79D5-4757-93B5-FC6B0ED0938DQ33668078-6817EA87-AADB-47EE-BB0C-013EE6C5A051Q33897355-70B060A6-6AAC-4B94-A5E1-690A339483FBQ34355665-47A551BB-4856-47C0-ACEC-B830AF98922EQ34484279-A61D2128-EC44-49A8-9DC9-E8E148C1B976Q34506855-9C97F506-4B8B-41A4-AF71-CDFFA60AF07FQ34566051-A9C32537-CB2D-4DDB-9A9C-E3374286E06CQ34648147-5F45A22C-9DF1-437E-941B-4F3CF29AF706Q34726882-00957880-AF23-44F3-B16E-6D1A904EB07EQ35040588-045CE5A6-456C-43B4-8F70-6F5CF0B7AF71Q35071700-C2102E9E-2FE3-45B0-A6A1-044D976D85CFQ35104478-AE48707E-F8E2-4D60-A8D3-45924EFBCC2BQ35124896-346D8DFB-1719-49A7-9476-92C1CC878F22Q35145911-645DA2DD-A873-41CA-A2D6-92CE1533A519Q35654254-BC696FAC-84CA-4E25-9EDB-DAC8AA441817Q35802995-C1973094-D6DE-4713-A114-C85B13129438Q35871084-C90AAC95-A59F-442A-B960-95EF92D2DAE8Q35909055-FB859ECD-08C6-431C-8DB3-85C0FC4F1D80Q35960520-BDAB77EB-5F26-4820-BBC9-78E597621871Q35996301-CD0674E9-C71F-471E-AF1A-4FD0F01B5D83Q36253614-B53CA337-328C-4583-802B-A8725DCE7F32Q36275002-3A16D810-6CB8-44A0-8109-F1F9F9AF33A1Q36466019-5890D40F-D3DA-4DB4-AC8F-ECF9A79F3667Q36527551-B45B0249-F373-4AA1-BACB-8A3639689392Q36530347-FB8420DF-67E7-4D2E-BBFD-383449B4C7DC
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Diabetes complications: the microRNA perspective.
@ast
Diabetes complications: the microRNA perspective.
@en
type
label
Diabetes complications: the microRNA perspective.
@ast
Diabetes complications: the microRNA perspective.
@en
prefLabel
Diabetes complications: the microRNA perspective.
@ast
Diabetes complications: the microRNA perspective.
@en
P2093
P2860
P356
P1433
P1476
Diabetes complications: the microRNA perspective
@en
P2093
Phillip Kantharidis
Rosemarie M Carew
P2860
P304
P356
10.2337/DB11-0082
P407
P50
P5008
P577
2011-07-01T00:00:00Z